TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) insider Tamer I. Khayal sold 5,000 shares of TransMedics Group stock in a transaction dated Tuesday, July 18th. The shares were sold at an average price of $95.37, for a total value of $476,850.00. Following the transaction, the insider now owns 14,375 shares of the company’s stock, […]
TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) CEO Waleed H. Hassanein sold 7,500 shares of TransMedics Group stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $82.51, for a total transaction of $618,825.00. Following the sale, the chief executive officer now directly owns 544,191 shares in the […]
Shares of TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) have been assigned an average recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month […]
TransMedics Group (NASDAQ:TMDX – Get Rating) issued its quarterly earnings data on Monday. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.17, Briefing.com reports. The company had revenue of $41.60 million for the quarter, compared to the consensus estimate of $36.05 million. TransMedics Group had […]
TransMedics Group (NASDAQ:TMDX – Get Rating) had its price objective lifted by stock analysts at Oppenheimer from $85.00 to $90.00 in a research report issued to clients and investors on Tuesday, The Fly reports. Oppenheimer’s target price would suggest a potential upside of 15.61% from the stock’s previous close. A number of other equities research […]